Skip to content

6-KAccepted Oct 13, 5:18 PM ET

AgomAb Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:18 PM

Oct 13, 2026

Filed

Oct 13, 2026

Documents

3

Size

37.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.